Overcoming the challenges of infrared photosensitizers in photodynamic therapy: the making of redaporfin
Chemical Communications · 2023 · 59 (62) · 9457-9468
DOI: 10.1039/d3cc02283h ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Communications, 2023. Verfasst von Luis G Arnaut und 1 weiteren Autor:innen. Beteiligte Einrichtung: CQC-IMS, Chemistry Department, University of Coimbra, Coimbra, Portugal. lgarnaut@ci.uc.pt. Hauptthemen laut MEDLINE: Photochemotherapy, Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: European Regional Development Fund, Fundação para a Ciência e a Tecnologia.
Abstract (Originalsprache)
We offer a personal account of the discovery and development of a photosensitizer for photodynamic therapy (PDT) of cancer, from bench to bedside.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CQC-IMS, Chemistry Department, University of Coimbra, Coimbra, Portugal. lgarnaut@ci.uc.pt.
Förderung
- European Regional Development Fund
- Fundação para a Ciência e a Tecnologia
Zitieren
APA
Arnaut, L. G., & Pereira, M. M. (2023). Overcoming the challenges of infrared photosensitizers in photodynamic therapy: the making of redaporfin. Chemical Communications, 59(62), 9457-9468. https://doi.org/10.1039/d3cc02283h
Vancouver
Arnaut LG, Pereira MM. Overcoming the challenges of infrared photosensitizers in photodynamic therapy: the making of redaporfin. Chemical Communications. 2023;59(62):9457-9468. doi:10.1039/d3cc02283h
BibTeX
@article{Arnaut2023,
author = {Arnaut, Luis G and Pereira, Mariette M},
title = {Overcoming the challenges of infrared photosensitizers in photodynamic therapy: the making of redaporfin},
journal = {Chemical Communications},
year = {2023},
volume = {59},
number = {62},
pages = {9457--9468},
doi = {10.1039/d3cc02283h}
}
EUVIMED